Healthcare provider profile · identity verified

Donald Klinestiver

Internal Medicine · PITTSBURGH, PA · NPI 1114904075

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	138
Levothyroxine Sodium	Levothyroxine Sodium	376	114
Lisinopril	Lisinopril	348	111
Amlodipine Besylate	Amlodipine Besylate	322	95
Hydrochlorothiazide	Hydrochlorothiazide	276	76
Simvastatin	Simvastatin	275	81
Pantoprazole Sodium	Pantoprazole Sodium	274	82
Metoprolol Succinate	Metoprolol Succinate	265	79
Losartan Potassium	Losartan Potassium	242	70
Rosuvastatin Calcium	Rosuvastatin Calcium	235	75
Omeprazole	Omeprazole	225	68
Eliquis	Apixaban	207	53
Metoprolol Tartrate	Metoprolol Tartrate	176	59
Tamsulosin Hcl	Tamsulosin Hcl	167	56
Metformin Hcl	Metformin Hcl	143	48
Albuterol Sulfate Hfa	Albuterol Sulfate	141	42
Furosemide	Furosemide	135	51
Gabapentin	Gabapentin	135	48
Duloxetine Hcl	Duloxetine Hcl	121	39
Meloxicam	Meloxicam	115	34
Fluticasone Propionate	Fluticasone Propionate	107	35
Trazodone Hcl	Trazodone Hcl	104	28
Citalopram Hbr	Citalopram Hydrobromide	103	28
Potassium Chloride	Potassium Chloride	100	32
Sertraline Hcl	Sertraline Hcl	97	34
Atenolol	Atenolol	94	26
Famotidine	Famotidine	87	28
Synthroid	Levothyroxine Sodium	86	21
Pravastatin Sodium	Pravastatin Sodium	85	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	15
Allopurinol	Allopurinol	79	25
Clopidogrel	Clopidogrel Bisulfate	72	22
Escitalopram Oxalate	Escitalopram Oxalate	70	21
Finasteride	Finasteride	70	18
Warfarin Sodium	Warfarin Sodium	66	16
Metformin Hcl Er	Metformin Hcl	65	21
Jardiance	Empagliflozin	62	13
Valsartan	Valsartan	61	18
Ozempic	Semaglutide	60	12
Breo Ellipta	Fluticasone/Vilanterol	51	suppressed
Alendronate Sodium	Alendronate Sodium	50	13
Carvedilol	Carvedilol	50	17
Clonidine Hcl	Clonidine Hcl	49	13
Fluoxetine Hcl	Fluoxetine Hcl	49	18
Propranolol Hcl Er	Propranolol Hcl	44	suppressed
Donepezil Hcl	Donepezil Hcl	43	14
Ropinirole Hcl	Ropinirole Hcl	43	14
Amitriptyline Hcl	Amitriptyline Hcl	41	12
Glipizide Er	Glipizide	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	13
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Memantine Hcl	Memantine Hcl	37	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	12
Ibuprofen	Ibuprofen	34	14
Prednisone	Prednisone	33	20
Xarelto	Rivaroxaban	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	14
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Bumetanide	Bumetanide	28	13
Irbesartan	Irbesartan	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Raloxifene Hcl	Raloxifene Hcl	24	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Glipizide	Glipizide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ketoconazole	Ketoconazole	22	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Baclofen	Baclofen	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Nitroglycerin	Nitroglycerin	21	14
Bupropion Xl	Bupropion Hcl	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Topiramate	Topiramate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Enalapril Maleate	Enalapril Maleate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Ramipril	Ramipril	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Ibu	Ibuprofen	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Verapamil Er	Verapamil Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Primidone	Primidone	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Nifedipine Er	Nifedipine	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Sulfasalazine Dr	Sulfasalazine	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Alprazolam	Alprazolam	11	11
Divalproex Sodium	Divalproex Sodium	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error